Xarelto is part of the “new generation” of blood thinners intended to replace Coumadin (warfarin), a drug which has been available and effective to Americans coping with atrial fibrillation (AFIb) since the 1950s. While claimed to be easier to monitor, there is no reversal agent for Xarelto. Along with two other drugs in the same class known as Pradaxa and Eliquis, it is believed they are linked to more than 8,000 deaths since 2010 according to the Milwaukee Journal Sentinel/MedPage.
Those numbers are shockingly high when compared to warfarin which was attributed to 700 deaths during the same time period.
Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer worked together to develop and market a drug that they saw a great financial opportunity in since millions of Americans use blood thinners each year. It is reported that together in 2015 Johnson & Johnson and Bayer sold about $2 billion worth of Xarelto, and in the first quarter of 2016, the drug had reportedly earned more than $567 million.
What Are Medical Professionals Saying?
According to the Knoxville News Sentinel, Rita Redberg, a cardiologist and editor of Journal of the American Medical Association, Internal Medicine said she has advised patients to wait a few years until the true risks and benefits of the new drugs are known.
“I don’t prescribe any of the newer oral anticoagulants,” said Redberg, a professor of medicine at the University of California, San Francisco. “My concern is that a lot of the people being put on the novel oral anticoagulants will have more harm than good.”
Common Injuries Reported
While all drugs often carry side effects, the fact that this drug and others like it may cause irreversible harm, including death, has been the focal point for thousands who have been hospitalized, or have died, and their families have pursued justice on their behalf. Common blood thinners like Coumadin require monitoring to be sure that bleeding is not present and no harm comes to the individual. This is how Xarelto’s popularity grew, as it did not require the monitoring due to its “low therapeutic index.” The inherent problem lies within this low therapeutic index, which closes the window between safely taking a blood thinner and having the drug become deadly.
Injuries arising out of Xarelto use include:
- Bleeding gums
- Excessive bleeding after a surgery
- Gastrointestinal bleeding
- Rectal bleeding
- Cerebral hemorrhaging
While most doctors and dentists have been aware their patients have been using Xarelto and little harm has been done, for common falls and slight injuries, Xarelto has been linked to fatalities.
FDA Rejects Xarelto Antidote
In August 2016 Portola Pharmaceuticals announced that the FDA did not approve the reversal antidote for Xarelto, leaving users of the drug in danger of uncontrollable bleeding. Pradaxa, a blood thinning drug similar to Xarleto, had it’s antidote Praxbind approved in October 2015. Xarelto’s reversal agent is known as AndexXa, and remains pending approval as the FDA reviews Portola’s post-marketing commitments.
More Than 5,000 Lawsuits Filed
If you or someone you love has been injured or died from the use of Xarelto, you are not alone. Since 2015 our lawyers have filed Xarelto lawsuits on behalf of individuals throughout the United States.
As of May 2016, more than 5,260 lawsuits had been filed in a Multi-District Litigation, a court which consolidates all cases on the same topic to increase the efficiency of the cases, and hopefully resolve these matters quickly on behalf of the claimants. Multiple Partners at Searcy Denney are involved in the litigation, holding leadership roles and representing individuals and families just like yourself.
While we can not turn back time or ease your loss, we do want to help. If you wish to hold the drug maker responsible, often a lawsuit is the only way to send the message among thousands of others. We can help make the process easy for you. You may contact our firm at any time by using our contact form, or by calling 800-388-3905.
If you or someone you love have been injured, please understand that time limits do apply! Please do not hesitate to contact us as we offer free consultations without obligation to hire our firm.
For the many of you who have our firm representing you, here is an update on litigation from firm Partner, Cal Warriner III: